Quantcast

Latest Clinical trial Stories

2014-10-08 08:25:59

SANTA ROSA, Calif., Oct. 8, 2014 /PRNewswire/ -- Ruthigen Inc. (NASDAQ: RTGN), a biopharmaceutical company focused on pioneering new therapies to improve patient outcomes and reduce healthcare costs associated with infections related to post-operative invasive procedures, announces the initiation of a Phase 1/2 clinical trial to evaluate the safety, tolerability, and potential efficacy of its lead drug candidate, RUT58-60, for use as an adjunct to systemic antibiotics in abdominal...

2014-10-07 16:26:23

WASHINGTON, Oct. 7, 2014 /PRNewswire-USNewswire/ -- Today, the Pharmaceutical Research and Manufacturers of America (PhRMA) released a new report, "Researching Cancer Medicines: Setbacks and Stepping Stones," which highlights the number of investigational cancer medicines that did not succeed in clinical trials and how these so-called "failures" are a critical part of the drug development process. http://photos.prnewswire.com/prnvar/20091027/PHRMALOGO The report illustrates the immense...

2014-10-07 08:28:56

MARLBOROUGH, Mass., Oct. 7, 2014 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced that a review of the first two enrolled patients' clinical photographs in the first Phase 2a clinical trial (RXI-109-1301), indicate that treatment with the Company's lead clinical candidate, RXI-109, may...

2014-10-06 16:26:39

WASHINGTON, Oct. 6, 2014 /PRNewswire-USNewswire/ -- America's biopharmaceutical research companies are currently developing nearly 800 new medicines and vaccines for cancer, according to a new report released today by the Pharmaceutical Research and Manufacturers of America (PhRMA). http://photos.prnewswire.com/prnvar/20091027/PHRMALOGO Cancer is the second leading cause of death in the United States, accounting for nearly one of every four deaths, according to the American Cancer...

2014-10-06 12:28:47

New Trials Will Be Designed to Address the Shortcomings of SYMPLICITY HTN-3, According to Findings from Decision Resources Group BURLINGTON, Mass., Oct. 6, 2014 /PRNewswire/ -- Decision Resources Group finds that the global hypertension management device market continues to hold considerable potential, despite recent setbacks. In the U.S., Europe and Japan, 200 million people are hypertensive, and many do not respond to medical therapy. Because hypertension can lead to major cardiovascular...

2014-10-06 08:27:47

WAYNE, Pa., Oct. 6, 2014 /PRNewswire/ -- Bracket, a leading clinical trial specialty services provider, today announced the addition of Jeffrey W. Kinell as Chief Executive Officer and as a new member of its Board of Directors. Jeff brings more than 30 years of experience to Bracket, primarily in leadership positions in growth oriented, health services and pharmaceutical outsourcing firms. Most recently, Jeff was CEO of CRI Lifetree, a mid-size specialized research organization focused in...

2014-10-05 23:00:43

MarketOptimizer.org adds “Intermittent Claudication Global Clinical Trials Review, H2, 2014” to its store. This report provides elemental information and data relating to the clinical trials on Intermittent Claudication. Dallas, Texas (PRWEB) October 05, 2014 New clinical trial report, “Intermittent Claudication Global Clinical Trials Review, H2, 2014″ provides data on the Intermittent Claudication clinical trial scenario. This report provides elemental information and data...

2014-10-03 23:00:25

SonaCare Medical FDA Panel Review for Its Sonablate® 450 Prostate Ablation System CHARLOTTE, NC (PRWEB) October 03, 2014 FRIDAY, OCTOBER 3, 2014 SonaCare Medical, LLC, a leader in minimally invasive high intensity focused ultrasound (HIFU) technology, announced that the Gastroenterology and Urology Device Panel met on Wednesday October 1st with representatives from the FDA and SonaCare Medical to review and vote on recommendations for the interim analysis of SonaCare Medical’s...

2014-10-02 23:00:46

Charity Ride Raised Funds to Support Cancer Research Goodyear, Ariz (PRWEB) October 02, 2014 GOODYEAR, AZ (October 2, 2014) – On Saturday September 27, 2014 nearly 800 cyclists of all ages and abilities took to the streets to overcome cancer at the second annual Trails 4 Trials Charity Ride (T4T) in Goodyear, Arizona. In the past two years, the event has raised more than $272,000 to help fund innovative cancer research. All donations benefited Gateway for Cancer ResearchSM, a 501(c)(3)...

2014-10-02 16:26:53

Dr. McNair to oversee WCG's team of 50 clinicians PRINCETON, N.J., Oct. 2, 2014 /PRNewswire/ -- WIRB-Copernicus Group (WCG), the world's largest provider of regulatory and ethical review services and software to support clinical research, announced today that Lindsay McNair M.D., M.P.H., M.S.B., has been promoted to chief medical officer. http://photos.prnewswire.com/prnvar/20140422/77410 "As a physician, clinical investigator, consultant, and former academic institutional review...


Word of the Day
ramage
  • Boughs or branches.
  • Warbling of birds in trees.
Related